GRUSF
Price
$0.39
Change
-$0.04 (-9.30%)
Updated
Sep 26 closing price
Capitalization
98.45M
INIS
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
33.69M
Interact to see
Advertisement

GRUSF vs INIS

Header iconGRUSF vs INIS Comparison
Open Charts GRUSF vs INISBanner chart's image
Grown Rogue International
Price$0.39
Change-$0.04 (-9.30%)
Volume$422.82K
Capitalization98.45M
International Isotopes
Price$0.06
Change-$0.00 (-0.00%)
Volume$45K
Capitalization33.69M
GRUSF vs INIS Comparison Chart in %
Loading...
GRUSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRUSF vs. INIS commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRUSF is a Hold and INIS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (GRUSF: $0.39 vs. INIS: $0.06)
Brand notoriety: GRUSF and INIS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GRUSF: 277% vs. INIS: 33%
Market capitalization -- GRUSF: $98.45M vs. INIS: $33.69M
GRUSF [@Pharmaceuticals: Generic] is valued at $98.45M. INIS’s [@Pharmaceuticals: Generic] market capitalization is $33.69M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRUSF’s FA Score shows that 0 FA rating(s) are green whileINIS’s FA Score has 1 green FA rating(s).

  • GRUSF’s FA Score: 0 green, 5 red.
  • INIS’s FA Score: 1 green, 4 red.
According to our system of comparison, INIS is a better buy in the long-term than GRUSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRUSF’s TA Score shows that 4 TA indicator(s) are bullish while INIS’s TA Score has 5 bullish TA indicator(s).

  • GRUSF’s TA Score: 4 bullish, 4 bearish.
  • INIS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INIS is a better buy in the short-term than GRUSF.

Price Growth

GRUSF (@Pharmaceuticals: Generic) experienced а -12.44% price change this week, while INIS (@Pharmaceuticals: Generic) price change was +5.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRUSF($98.5M) has a higher market cap than INIS($33.7M). INIS YTD gains are higher at: 85.465 vs. GRUSF (-39.806). GRUSF has higher annual earnings (EBITDA): 10.2M vs. INIS (855K). GRUSF has more cash in the bank: 9.25M vs. INIS (1.86M). INIS has less debt than GRUSF: INIS (4.82M) vs GRUSF (13.2M). GRUSF has higher revenues than INIS: GRUSF (23.8M) vs INIS (14.7M).
GRUSFINISGRUSF / INIS
Capitalization98.5M33.7M292%
EBITDA10.2M855K1,193%
Gain YTD-39.80685.465-47%
P/E Ratio19.70N/A-
Revenue23.8M14.7M162%
Total Cash9.25M1.86M498%
Total Debt13.2M4.82M274%
FUNDAMENTALS RATINGS
GRUSF vs INIS: Fundamental Ratings
GRUSF
INIS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
6197
SMR RATING
1..100
5488
PRICE GROWTH RATING
1..100
6556
P/E GROWTH RATING
1..100
716
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GRUSF's Valuation (61) in the null industry is in the same range as INIS (83). This means that GRUSF’s stock grew similarly to INIS’s over the last 12 months.

GRUSF's Profit vs Risk Rating (61) in the null industry is somewhat better than the same rating for INIS (97). This means that GRUSF’s stock grew somewhat faster than INIS’s over the last 12 months.

GRUSF's SMR Rating (54) in the null industry is somewhat better than the same rating for INIS (88). This means that GRUSF’s stock grew somewhat faster than INIS’s over the last 12 months.

INIS's Price Growth Rating (56) in the null industry is in the same range as GRUSF (65). This means that INIS’s stock grew similarly to GRUSF’s over the last 12 months.

INIS's P/E Growth Rating (6) in the null industry is somewhat better than the same rating for GRUSF (71). This means that INIS’s stock grew somewhat faster than GRUSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GRUSFINIS
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 13 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GRUSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JPSWY32.262.26
+7.54%
The Japan Steel Works, Ltd.
SOUB21.500.35
+1.65%
Southpoint Bancshares Inc.
STMEF28.00N/A
N/A
STMicroelectronics N.V.
SHMY3.00N/A
N/A
SYNERGY EMPIRE LTD.
HKHC38.00-0.33
-0.86%
Horizon Kinetics Holding Corporation

GRUSF and

Correlation & Price change

A.I.dvisor tells us that GRUSF and GLASF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRUSF and GLASF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRUSF
1D Price
Change %
GRUSF100%
-8.37%
GLASF - GRUSF
32%
Poorly correlated
-0.46%
CRLBF - GRUSF
29%
Poorly correlated
-1.90%
CURLF - GRUSF
28%
Poorly correlated
-7.35%
TSNDF - GRUSF
27%
Poorly correlated
-2.69%
CXXIF - GRUSF
25%
Poorly correlated
-5.04%
More

INIS and

Correlation & Price change

A.I.dvisor tells us that INIS and HSTI have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INIS and HSTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INIS
1D Price
Change %
INIS100%
-0.31%
HSTI - INIS
10%
Poorly correlated
N/A
HTSUF - INIS
10%
Poorly correlated
N/A
IPSEY - INIS
7%
Poorly correlated
-6.02%
GRUSF - INIS
7%
Poorly correlated
-8.37%
KHTRF - INIS
3%
Poorly correlated
N/A
More